RedHill Biopharma Capital Expenditures (CapEx) Growth & History (RDHL)

RedHill Biopharma's capital expenditures (capex) was $5,000 for fiscal 2025.

View full RedHill Biopharma company overview

RedHill Biopharma annual capital expenditures (capex) history

RedHill Biopharma annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$5,000−$4,000−44.44%
20242024-12-31$9,000−$2,000−18.18%
20232023-12-31$11,000−$187,000−94.44%
20222022-12-31$198,000$83,000+72.17%
20212021-12-31$115,000−$291,000−71.67%
20202020-12-31$406,000$238,000+141.67%
20192019-12-31$168,000$145,000+630.43%
20182018-12-31$23,000−$123,000−84.25%
20172017-12-31$146,000$61,000+71.76%
20162016-12-31$85,000$71,000+507.14%
20152015-12-31$14,000

RedHill Biopharma capital expenditures (capex) trends

Over the last five fiscal years, RedHill Biopharma's capital expenditures (capex) decreased from $406,000 to $5,000, a change of −$401,000. The latest reported quarter, Q2 2022, shows $163,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review RedHill Biopharma source filings ↗

Community posts

It’s quiet here.

No posts about RDHL yet. Start the conversation.

Write the first post